Revvity | PKI - 销售毛利

股票价格
82.28
每天变化
-2.90 -3.40%
每月一次
-2.95%
每年
-11.93%
Q2 预测
84.91


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 10.3B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


销售毛利 更改 日
Agilent USD 946M 44M 2025-12
Align Technology USD 683.59M 44.39M 2025-12
Bio Techne USD 191.28M 3.16M 2025-12
Bio-Rad Laboratories USD 343.4M 1.9M 2025-09
Bruker USD 449.2M 69.8M 2025-12
Celltrion KRW 626.11B 81.75B 2025-09
Charles River Laboratories USD 271.96M 39.43M 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 443M 2M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Illumina USD 759M 26M 2025-12
Intuitive Surgical USD 1.83B 73.8M 2026-03
IQVIA Holdings USD 1.12B 32M 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Laboratory Of America USD 993.2M 31.9M 2025-12
Medical Developments International AUD 7.35M 7.37M 2025-06
Mesa Laboratories USD 39.75M 4.3M 2024-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
OraSure Technologies USD 11.34M 435K 2025-12
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Pharma Mar EUR 86.7M 53.34M 2025-12
Qiagen NV USD 325.27M 19.53M 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Quidel USD 274.8M 1.01B 2025-12
Repligen USD 103.83M 3.32M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tilray USD 57.47M 10.16M 2025-06
Waters USD 557.42M 97.44M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06